Xinchaotuo (sacubatril/allisartan)
/ Shenzhen Salubris
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 31, 2025
A multicenter, randomized, double-blind, parallel controlled Phase III clinical study to evaluate the efficacy and safety of S086 combined with amlodipine in patients with essential hypertension whose
(ChiCTR)
- P3 | N=338 | Completed | Sponsor: Peking University First Hospital; Peking University First Hospital
Monotherapy • New P3 trial • Cardiovascular • Hypertension
September 23, 2022
S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction
(clinicaltrials.gov)
- P3 | N=5 | Recruiting | Sponsor: Shenzhen People's Hospital
New P3 trial • Cardiovascular • Congestive Heart Failure • Heart Failure
1 to 2
Of
2
Go to page
1